Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
19
KMTS Quote, Financials, Valuation and Earnings
Last price:
$22.42
Seasonality move
:
--
Day range:
$22.17 - $23.36
52-week range:
$13.25 - $30.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.85x
P/B ratio:
6.66x
Volume:
493.7K
Avg. volume:
244.7K
1-year change:
--
Market cap:
$1.1B
Revenue:
$59.8M
EPS (TTM):
-$2.68
Analysts' Opinion
-
Consensus RatingKestra Medical Technologies Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $29.00, Kestra Medical Technologies Ltd. has an estimated upside of 26.53% from its current price of $22.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $24.00 representing 100% downside risk from its current price of $22.92.
Fair Value
-
According to the consensus of 6 analysts, Kestra Medical Technologies Ltd. has 26.53% upside to fair value with a price target of $29.00 per share.
KMTS vs. S&P 500
-
Over the past 5 trading days, Kestra Medical Technologies Ltd. has underperformed the S&P 500 by -11.81% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kestra Medical Technologies Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kestra Medical Technologies Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Kestra Medical Technologies Ltd. reported revenues of $22.6M.
Earnings Growth
-
Kestra Medical Technologies Ltd. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Kestra Medical Technologies Ltd. reported earnings per share of -$0.64.
Enterprise value:
961.5M
EV / Invested capital:
--
Price / LTM sales:
15.85x
EV / EBIT:
--
EV / Revenue:
12.95x
PEG ratio (5yr expected):
-0.20x
EV / Free cash flow:
-8.39x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$34.5M
Return On Assets:
-63.04%
Net Income Margin (TTM):
-177.06%
Return On Equity:
-105.99%
Return On Invested Capital:
-77.65%
Operating Margin:
-140.73%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | -- | $45.8M | $74.3M | $14.7M | $22.6M | |
| Gross Profit | -$1.9M | $12.3M | $34.5M | $5.8M | $11.4M | |
| Operating Income | -- | -$77.9M | -$129.4M | -$19.1M | -$31.8M | |
| EBITDA | -- | -$35.8M | -$121.3M | -$17.3M | -$29.4M | |
| Diluted EPS | -$1.07 | -$1.89 | -$2.68 | -$0.48 | -$0.64 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $87.9M | $195.4M | |
| Total Assets | -- | -- | -- | $126.1M | $246.7M | |
| Current Liabilities | -- | -- | -- | $31.3M | $35.8M | |
| Total Liabilities | -- | -- | -- | $82.1M | $82.6M | |
| Total Equity | -- | -- | -- | $44M | $164.1M | |
| Total Debt | -- | -- | -- | $46.1M | $44.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$66.3M | -$86.7M | -$18.1M | -$18.3M | |
| Cash From Investing | -- | -$20.6M | -$10.4M | -$4.4M | -$7.4M | |
| Cash From Financing | -- | $139.8M | $195.6M | -$575K | -$27K | |
| Free Cash Flow | -- | -$86.9M | -$114.6M | -$22.7M | -$25.8M | |
KMTS
Sector
Market Cap
$1.1B
$25.3M
Price % of 52-Week High
76.4%
49.41%
Dividend Yield
0%
0%
Shareholder Yield
-15.68%
-1.6%
1-Year Price Total Return
--
-17.71%
Beta (5-Year)
--
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$24.79
200-day SMA
Buy
Level
$22.19
Bollinger Bands (100)
Sell
Level
23.96 - 27.06
Chaikin Money Flow
Buy
Level
2.1M
20-day SMA
Sell
Level
$25.69
Relative Strength Index (RSI14)
Sell
Level
34.96
ADX Line
Sell
Level
15.74
Williams %R
Buy
Level
-87.5415
50-day SMA
Sell
Level
$25.41
MACD (12, 26)
Sell
Level
-0.45
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
10M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.0491)
Sell
CA Score
(Annual)
Level (-3.0997)
Sell
Beneish M-Score
(Annual)
Level (-1.7818)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (2.5512)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. It focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Traci S. Umberger in 2014 and is headquartered in Kirkland, WA.
Stock Forecast FAQ
In the current month, KMTS has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The KMTS average analyst price target in the past 3 months is $29.00.
-
Where Will Kestra Medical Technologies Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kestra Medical Technologies Ltd. share price will rise to $29.00 per share over the next 12 months.
-
What Do Analysts Say About Kestra Medical Technologies Ltd.?
Analysts are divided on their view about Kestra Medical Technologies Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kestra Medical Technologies Ltd. is a Sell and believe this share price will drop from its current level to $24.00.
-
What Is Kestra Medical Technologies Ltd.'s Price Target?
The price target for Kestra Medical Technologies Ltd. over the next 1-year time period is forecast to be $29.00 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is KMTS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kestra Medical Technologies Ltd. is a Buy. 5 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of KMTS?
You can purchase shares of Kestra Medical Technologies Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kestra Medical Technologies Ltd. shares.
-
What Is The Kestra Medical Technologies Ltd. Share Price Today?
Kestra Medical Technologies Ltd. was last trading at $22.42 per share. This represents the most recent stock quote for Kestra Medical Technologies Ltd.. Yesterday, Kestra Medical Technologies Ltd. closed at $22.92 per share.
-
How To Buy Kestra Medical Technologies Ltd. Stock Online?
In order to purchase Kestra Medical Technologies Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get KMTS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KMTS
Sector
P/E ratio
--
22.85x
PEG ratio
-0.20x
-0.01x
P/B ratio
6.66x
1.78x
Price / LTM sales
15.85x
1.52x
Growth Metrics
KMTS
Sector
Revenue growth
53.4%
3.33%
Earnings growth
-33.41%
11.64%
Revenue (5-year growth)
--
6.41%
Earnings forecast
-$0.60
-$0.20
Profitability
KMTS
Sector
Profitability FY 2025
$24.2M
$2.3M
Return on invested capital
-77.65%
-33.31%
Return on assets
-63.04%
-29.79%
Return on equity
-105.99%
-38.98%
Earnings Date
Last Earnings Date
Dec
11
Next Earnings Date
Mar
17
Estimated Next Earnings Date
Mar
12
Balance Sheet
KMTS
Sector
Total cash
$175.4M
$24.1M
Short term investments
--
$23.8M
Total assets
$295.7M
$70.1M
Long term debt
$44.7M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
34
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
46
ZD alert for Mar 4
Ziff Davis, Inc. [ZD] is up 3.64% over the past day.
Buy
54
KORU alert for Mar 4
Direxion Daily MSCI South Korea Bull 3X Shares [KORU] is up 5.43% over the past day.
Sell
40
PSIX alert for Mar 4
Power Solutions International, Inc. [PSIX] is down 1.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
